A Study to Evaluate the Effect of Sodium Zirconium Cyclosilicate on Chronic Kidney Disease (CKD) Progression in Participants With CKD and Hyperkalaemia or at Risk of Hyperkalaemia
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Glenn M. Chertow, MD, MPH
Stanford University School of Medicine, Stanford, CA USA
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
276 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Research Site
Buenos Aires, Argentina
- Research Site
Buenos Aires, Argentina
- Research Site
CABA, Argentina
- Research Site
La Plata, Argentina
- Research Site
Mar del Plata, Argentina
- Research Site
Mar del Plata, Argentina
- Research Site
Rosario, Argentina
- Research Site
San Vicente, Argentina
- Research Site
Sarandí, Argentina
- Research Site
Curitiba, Brazil
- Research Site
Fortaleza, Brazil
- Research Site
Joinville, Brazil
- Research Site
Maringá, Brazil
- Research Site
Porto Alegre, Brazil
- Research Site
Porto Alegre, Brazil
- Research Site
São Paulo, Brazil
- Research Site
São Paulo, Brazil
- Research Site
Blagoevgrad, Bulgaria
- Research Site
Botevgrad, Bulgaria
- Research Site
Dupnitsa, Bulgaria
- Research Site
Gorna Oryahovitsa, Bulgaria
- Research Site
Gotse Delchev, Bulgaria
- Research Site
Kozloduy, Bulgaria
- Research Site
Lom, Bulgaria
- Research Site
Pleven, Bulgaria
- Research Site
Plovdiv, Bulgaria
- Research Site
Plovdiv, Bulgaria
- Research Site
Plovdiv, Bulgaria
- Research Site
Samokov, Bulgaria
- Research Site
Sandanski, Bulgaria
- Research Site
Silistra, Bulgaria
- Research Site
Sliven, Bulgaria
- Research Site
Smolyan, Bulgaria
- Research Site
Stara Zagora, Bulgaria
- Research Site
Yambol, Bulgaria
- Research Site
Saint John, New Brunswick, Canada
- Research Site
Oshawa, Ontario, Canada
- Research Site
Montreal, Quebec, Canada
- Research Site
Montreal, Quebec, Canada
- Research Site
Baotou, China
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2021
- Primary completion
- 7 Feb 2024
- Completion
- 7 Feb 2024
- Last update posted
- 8 Jan 2026
- Registered enrollment
- 1,112
- Registry id
- NCT05056727
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.